- Home
- ONCY vs NVNO Comparison
ONCY vs NVNO Comparison
Compare ONCY & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- NVNO
- Stock Information
- Founded
- ONCY 1998
- NVNO 1987
- Country
- ONCY Canada
- NVNO United States
- Employees
- ONCY N/A
- NVNO N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- NVNO Medical/Dental Instruments
- Sector
- ONCY Health Care
- NVNO Health Care
- Exchange
- ONCY Nasdaq
- NVNO Nasdaq
- Market Cap
- ONCY 56.2M
- NVNO 62.4M
- IPO Year
- ONCY 1999
- NVNO N/A
- Fundamental
- Price
- ONCY $0.73
- NVNO $3.77
- Analyst Decision
- ONCY Strong Buy
- NVNO
- Analyst Count
- ONCY 2
- NVNO 0
- Target Price
- ONCY $4.00
- NVNO N/A
- AVG Volume (30 Days)
- ONCY 563.2K
- NVNO 93.5K
- Earning Date
- ONCY 03-06-2025
- NVNO 03-03-2025
- Dividend Yield
- ONCY N/A
- NVNO N/A
- EPS Growth
- ONCY N/A
- NVNO N/A
- EPS
- ONCY N/A
- NVNO N/A
- Revenue
- ONCY N/A
- NVNO N/A
- Revenue This Year
- ONCY N/A
- NVNO N/A
- Revenue Next Year
- ONCY N/A
- NVNO N/A
- P/E Ratio
- ONCY N/A
- NVNO N/A
- Revenue Growth
- ONCY N/A
- NVNO N/A
- 52 Week Low
- ONCY $0.67
- NVNO $2.45
- 52 Week High
- ONCY $1.53
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- ONCY 40.10
- NVNO 67.71
- Support Level
- ONCY $0.71
- NVNO $3.48
- Resistance Level
- ONCY $0.79
- NVNO $3.80
- Average True Range (ATR)
- ONCY 0.04
- NVNO 0.26
- MACD
- ONCY 0.00
- NVNO 0.06
- Stochastic Oscillator
- ONCY 32.71
- NVNO 90.80
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).